Optimizing Lymphedema Management After Breast Cancer: Predictive Risk Models in Clinical Practice
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.28146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Enrique Cano-Lallave und 7 weiteren Autor:innen. Beteiligte Einrichtung: Rehabilitation Service, University Hospital of Salamanca, Salamanca, Spain. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymphedema, Lymph Node Excision, Postoperative Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Objectives Lymphedema secondary to multimodal breast cancer treatment is a relatively common complication that significantly impacts patients' quality of life. Despite identifying several associated risk factors, accurately assessing individual risk remains challenging. This study aims to develop predictive tools integrating patient characteristics, tumor attributes, and treatment modalities to optimize clinical surveillance, enhance prevention, and enable earlier diagnosis.
Methods
Data were analyzed from 309 patients referred to the Lymphedema Unit of Rehabilitation Service who underwent lymphadenectomy for breast cancer between January 2016 and December 2021. Collected variables included patient demographics, tumor clinicopathological features, and treatment details. A lymphedema incidence study was conducted, complemented by univariate and multivariate regression analyses to identify risk factors. A nomogram was developed to predict high‐risk patients, facilitating personalized prevention and management strategies.
Results
The cumulative incidence of lymphedema was 18.4%. Independent risk factors included high body mass index, sedentary lifestyle, number of positive nodes (N stage), and radiotherapy, particularly targeting the breast, axilla, and supra‐infraclavicular regions. The logistic regression model demonstrated an area under the ROC curve (AUC) of 0.75, with acceptable calibration, validating the predictive model.
Conclusions
The predictive tools developed provide healthcare professionals with a means to identify patients at elevated risk of lymphedema, supporting individualized prevention and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rehabilitation Service, University Hospital of Salamanca, Salamanca, Spain.
- Department of Statistics, University of Salamanca, Salamanca, Spain.
- Department of General and Gastrointestinal Surgery, Breast Unit, University Hospital of Salamanca, Universidad de Salamanca, Salamanca, Spain.
ORCID-Profile: Elisa Frutos-Bernal
Zitieren
APA
Cano-Lallave, E., Frutos-Bernal, E., Anciones-Polo, M., Serrano-Sánchez, E., Rodríguez-Guerrero, I., Cuenda-Gamboa, P., Muñoz-Bellvis, L., & Eguía-Larrea, M. (2025). Optimizing Lymphedema Management After Breast Cancer: Predictive Risk Models in Clinical Practice. Journal of Surgical Oncology. https://doi.org/10.1002/jso.28146
Vancouver
Cano-Lallave E, Frutos-Bernal E, Anciones-Polo M, Serrano-Sánchez E, Rodríguez-Guerrero I, Cuenda-Gamboa P, et al. Optimizing Lymphedema Management After Breast Cancer: Predictive Risk Models in Clinical Practice. Journal of Surgical Oncology. 2025. doi:10.1002/jso.28146
BibTeX
@article{CanoLallave2025,
author = {Cano-Lallave, Enrique and Frutos-Bernal, Elisa and Anciones-Polo, María and Serrano-Sánchez, Esther and Rodríguez-Guerrero, Ian and Cuenda-Gamboa, Paula and Muñoz-Bellvis, Luis and Eguía-Larrea, Marta},
title = {Optimizing Lymphedema Management After Breast Cancer: Predictive Risk Models in Clinical Practice},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.28146}
}
EUVIMED